The invention relates to an absorbent solution and to a method using this solution for removing acid compounds contained in a gaseous effluent, comprising water and at least one diamine with general formula (I) as follows: ##STR00001## wherein: radicals R.sub.1, R.sub.2, R.sub.3 are each selected indiscriminately among a methyl radical and a hydroxyethyl radical, and at least one radical among R.sub.1, R.sub.2, R.sub.3 is a methyl radical.

The invention relates to an absorbent solution and to a method using this solution for removing acid compounds contained in a gaseous effluent, comprising water and at least one diamine with general formula (I) as follows: ##STR00001## wherein: radicals R.sub.1, R.sub.2, R.sub.3 are each selected indiscriminately among a methyl radical and a hydroxyethyl radical, and at least one radical among R.sub.1, R.sub.2, R.sub.3 is a methyl radical.

Compounds, pharmaceutical compositions, and methods for treating cancer, in particular brain cancer, are provided, including amphiphilic fatty acid/alcohol ethers (AlPs) comprising endocannabinoid and FABP motifs covalently linked to a beta-adrenoreceptor antagonist motif in one molecule. The invention includes methods for inhibiting growth of brain cancer cells by contacting the compound(s) with brain cancer cells. The invention provides a method for treating both brain cancer and brain cancer metastases, and for suppression of regrowth of brain cancer cells after radiation, surgical treatment, or chemotherapy of brain cancer. The invention also comprises an optimized chemical synthesis of the AIP compounds and methods of using the compounds, alone or in combination with another agent, for suppressing the growth of brain cancer cells, and enhancing survival of normal CNS cells, or improving recuperation from radiation, surgical or chemotherapy.

Compounds, pharmaceutical compositions, and methods for treating cancer, in particular brain cancer, are provided, including amphiphilic fatty acid/alcohol ethers (AlPs) comprising endocannabinoid and FABP motifs covalently linked to a beta-adrenoreceptor antagonist motif in one molecule. The invention includes methods for inhibiting growth of brain cancer cells by contacting the compound(s) with brain cancer cells. The invention provides a method for treating both brain cancer and brain cancer metastases, and for suppression of regrowth of brain cancer cells after radiation, surgical treatment, or chemotherapy of brain cancer. The invention also comprises an optimized chemical synthesis of the AIP compounds and methods of using the compounds, alone or in combination with another agent, for suppressing the growth of brain cancer cells, and enhancing survival of normal CNS cells, or improving recuperation from radiation, surgical or chemotherapy.

N-hydroxyalkylated polyamines, methods of making N-hydroxyalkylated polyamines, and drilling fluids containing N-hydroxyalkylated polyamines are provided, in which the N-hydroxyalkylated polyamine includes Formula (I): ##STR00001##
where R.sup.1 and R.sup.2 are independently a C or CH group; R.sup.3 is an aliphatic hydrocarbyl; R.sup.4 and R.sup.5 are independently acyclic hydrocarbyls, or R.sup.1, R.sup.2, R.sup.4, and R.sup.5 are covalently connected to form a cyclic hydrocarbyl; and R.sup.6, R.sup.7, R.sup.8, and R.sup.9 are independently acyclic hydrocarbyls or acyclic heterohydrocarbyls.

N-hydroxyalkylated polyamines, methods of making N-hydroxyalkylated polyamines, and drilling fluids containing N-hydroxyalkylated polyamines are provided, in which the N-hydroxyalkylated polyamine includes Formula (I): ##STR00001##
where R.sup.1 and R.sup.2 are independently a C or CH group; R.sup.3 is an aliphatic hydrocarbyl; R.sup.4 and R.sup.5 are independently acyclic hydrocarbyls, or R.sup.1, R.sup.2, R.sup.4, and R.sup.5 are covalently connected to form a cyclic hydrocarbyl; and R.sup.6, R.sup.7, R.sup.8, and R.sup.9 are independently acyclic hydrocarbyls or acyclic heterohydrocarbyls.

A white light emitting material having a chemical structural formula represented by formula (I), a preparation method thereof and application thereof. The preparation method comprises subjecting tris(4-iodophenyl)amine and 4-methoxyphenylacetylene or tris(4-iodophenyl)amine and methyl 4-ethynylbenzoate to a coupling reaction under protection of a protective gas and catalysis of a Pd/Cu mixed catalyst, to obtain the white light emitting material. A novel temperature-sensitive light emitting material is synthesized through a one-step method. The material is applied to the field of diode luminescence based on the temperature-sensitive characteristic. White light luminescence can be finally realized only by reasonably controlling the temperature and duration time during heating a substrate. Compared with the existing art, the method greatly saves raw material costs and manufacturing process costs, and provides a novel idea and strategy for use of a white organic light emitting diode.

A white light emitting material having a chemical structural formula represented by formula (I), a preparation method thereof and application thereof. The preparation method comprises subjecting tris(4-iodophenyl)amine and 4-methoxyphenylacetylene or tris(4-iodophenyl)amine and methyl 4-ethynylbenzoate to a coupling reaction under protection of a protective gas and catalysis of a Pd/Cu mixed catalyst, to obtain the white light emitting material. A novel temperature-sensitive light emitting material is synthesized through a one-step method. The material is applied to the field of diode luminescence based on the temperature-sensitive characteristic. White light luminescence can be finally realized only by reasonably controlling the temperature and duration time during heating a substrate. Compared with the existing art, the method greatly saves raw material costs and manufacturing process costs, and provides a novel idea and strategy for use of a white organic light emitting diode.

The present invention relates to a process for the conversion of ethylene oxide to 2-aminoethanol and/or Di(2-hydroxyethyl)amine comprising (i) providing a catalyst comprising a zeolitic material comprising YO2 and X2O3 in its framework structure, wherein Y is a tetravalent element and X is a trivalent element, wherein the zeolitic material has a framework-type structure selected from the group consisting of MFI and/or MEL, including MEL/MFI intergrowths, and wherein the zeolitic material contains one or more rare earth elements; (ii) providing a mixture in the liquid phase comprising ethylene oxide and ammonia; (iii) contacting the catalyst provided in (i) with the mixture in the liquid phase provided in (ii) for converting ethylene oxide to 2-aminoethanol and/or Di(2-hydroxyethyl)amine, wherein the catalyst provided in (i) is obtained and/or obtainable by a process comprising loading one or more salts of the one or more rare earth elements into the pores of the porous structure of the zeolitic material and optionally on the surface of the zeolitic material.

The present invention relates to a process for the conversion of ethylene oxide to 2-aminoethanol and/or Di(2-hydroxyethyl)amine comprising (i) providing a catalyst comprising a zeolitic material comprising YO2 and X2O3 in its framework structure, wherein Y is a tetravalent element and X is a trivalent element, wherein the zeolitic material has a framework-type structure selected from the group consisting of MFI and/or MEL, including MEL/MFI intergrowths, and wherein the zeolitic material contains one or more rare earth elements; (ii) providing a mixture in the liquid phase comprising ethylene oxide and ammonia; (iii) contacting the catalyst provided in (i) with the mixture in the liquid phase provided in (ii) for converting ethylene oxide to 2-aminoethanol and/or Di(2-hydroxyethyl)amine, wherein the catalyst provided in (i) is obtained and/or obtainable by a process comprising loading one or more salts of the one or more rare earth elements into the pores of the porous structure of the zeolitic material and optionally on the surface of the zeolitic material.